Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
The Journal of Investigative Dermatology
|
September 27, 2021
MFN2 Stabilization: A Bridge for Endoplasmic Reticulum Stress Sensitivity in Melanoma
Charles H Adelmann, Inbal Rachmin, David E Fisher
Methods in Molecular Biology (Clifton, N.J.)
|
December 14, 2018
Genome-Wide CRISPR/Cas9 Screening for Identification of Cancer Genes in Cell Lines
Charles H Adelmann, Tim Wang, David M Sabatini, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Lysosomal reduced thiols are essential for mouse embryonic development
Charles H Adelmann, Avanthika Venkatachalam, Lingjuan Huang, et al.
Cell Metabolism
|
March 2, 2021
CRISPR screens in physiologic medium reveal conditionally essential genes in human cells
Nicholas J Rossiter, Kimberly S Huggler, Charles H Adelmann, et al.
Nature
|
November 19, 2020
MFSD12 mediates the import of cysteine into melanosomes and lysosomes
Charles H Adelmann, Anna K Traunbauer, Brandon Chen, et al.
Oncotarget
|
March 31, 2016
Comparative profiles of BRAF inhibitors: the paradox index as a predictor of clinical toxicity
Charles H Adelmann, Grace Ching, Lili Du, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 23, 2021
Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction
Kendall J Condon, Jose M Orozco, Charles H Adelmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 2025
Lysosomal reduced thiols are essential for mouse embryonic development
Charles H Adelmann, Avanthika Venkatachalam, Lingjuan Huang, et al.
ACS Medicinal Chemistry Letters
|
January 16, 2015
Quantification of a Pharmacodynamic ERK End Point in Melanoma Cell Lysates: Toward Personalized Precision Medicine
Mangalika Warthaka, Charles H Adelmann, Tamer S Kaoud, et al.
Molecular Cancer Therapeutics
|
October 31, 2013
Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK
Harina Vin, Grace Ching, Sandra S Ojeda, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
The Journal of Investigative Dermatology
|
September 27, 2021
MFN2 Stabilization: A Bridge for Endoplasmic Reticulum Stress Sensitivity in Melanoma
Charles H Adelmann, Inbal Rachmin, David E Fisher
Methods in Molecular Biology (Clifton, N.J.)
|
December 14, 2018
Genome-Wide CRISPR/Cas9 Screening for Identification of Cancer Genes in Cell Lines
Charles H Adelmann, Tim Wang, David M Sabatini, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Lysosomal reduced thiols are essential for mouse embryonic development
Charles H Adelmann, Avanthika Venkatachalam, Lingjuan Huang, et al.
Cell Metabolism
|
March 2, 2021
CRISPR screens in physiologic medium reveal conditionally essential genes in human cells
Nicholas J Rossiter, Kimberly S Huggler, Charles H Adelmann, et al.
Nature
|
November 19, 2020
MFSD12 mediates the import of cysteine into melanosomes and lysosomes
Charles H Adelmann, Anna K Traunbauer, Brandon Chen, et al.
Oncotarget
|
March 31, 2016
Comparative profiles of BRAF inhibitors: the paradox index as a predictor of clinical toxicity
Charles H Adelmann, Grace Ching, Lili Du, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 23, 2021
Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction
Kendall J Condon, Jose M Orozco, Charles H Adelmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 2025
Lysosomal reduced thiols are essential for mouse embryonic development
Charles H Adelmann, Avanthika Venkatachalam, Lingjuan Huang, et al.
ACS Medicinal Chemistry Letters
|
January 16, 2015
Quantification of a Pharmacodynamic ERK End Point in Melanoma Cell Lysates: Toward Personalized Precision Medicine
Mangalika Warthaka, Charles H Adelmann, Tamer S Kaoud, et al.
Molecular Cancer Therapeutics
|
October 31, 2013
Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK
Harina Vin, Grace Ching, Sandra S Ojeda, et al.
Page
of 2